Photo Credit: Yossi Zeliger / Flash 90
Economics Minister Eli Cohen attends the Eli Horowitz Conference for Economy and Society, organized by Israel Democracy Institute in Jerusalem on June 19, 2017.

Israel’s Minister of Economy Eli Cohen is currently visiting Japan, where he is meeting with government officials and business leaders.

Cohen met on Tuesday with the CEO of Tokyo-based ORIX Corporation, a financial services group holding an investment portfolio with energy, infrastructure, transportation and real estate assets in nearly 40 countries around the world.


This past July, ORIX became the largest shareholder in Israel’s Ormat Technologies, paying $630 million for a 22.1 percent stake in the firm and bringing Stan Koyanagi and Yuichi Nishigori on to the board. Todd Freeland became the new chairman.

Cohen also met with the CEO of Mitsubishi Tanabe Pharma Corporation, a member of the Mitsubishi UFJ Financial Group, which acquired the Israeli pharmaceutical firm NeuroDerm Ltd. for $1.1 billion this past July as well.

The Rehovot-based clinical-stage pharmaceutical company, founded in 2003, develops next-generation treatments for central nervous system disorders. When it was acquired in July, NeuroDerm had three clinical-stage product candidates in development that offer a form of treatment for nearly every patient with Parkinson’s disease spanning the range of severity of the illness.


Previous articleBroadcasting Torah: An Interview With Israeli Journalist Sivan Rahav-Meir
Next articleLetters To The Editor
Hana Levi Julian is a Middle East news analyst with a degree in Mass Communication and Journalism from Southern Connecticut State University. A past columnist with The Jewish Press and senior editor at Arutz 7, Ms. Julian has written for, and other media outlets, in addition to her years working in broadcast journalism.